Rossari Biotech Limited
NSE: ROSSARI · Specialty Chemicals · sector
₹406.35NSE close 2026-10-26
Key numbers
Market cap₹2,251 cr
Price₹406.35
52w high / low₹663 / ₹375
P/E14.7xSector median 22.6x
P/B1.6xSector median 2.6x
Book value₹254.1
Dividend yield0.13%Sector median 0.60%
ROE11.5%Sector median 10.6%
ROCE13.5%Sector median 12.9%
OPM11.8%Sector median 12.1%
Debt / equity0.26xSector median 0.18x
EV/EBITDA7.9xSector median 15.1x
Interest cover6.5x
Current ratio1.62x
Sales growth 3y+13.1%Sector median +5.0%
Profit growth 3y+11.6%Sector median +0.9%
PEG1.28x
Last 12 months to Sep 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹127 cr vs borrowings ₹408 cr (FY26): borrowings are higher by ₹281 cr.
- Borrowings rose in each of the last 3 years (₹74 cr → ₹408 cr).
- Operating profit covered interest 6.5x in the last 12 months.
- Operating cash flow was below net profit in 3 of the last 5 years (FY26, FY24, FY22).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 15% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹406.35 on 2026-10-26: -38.7% from the 52-week high, +8.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹936.30 · low ₹388.75
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 513 | 580 | 544 | 586 | 582 | 685 | 697 | 698 |
| EBITDA | 65 | 69 | 68 | 72 | 69 | 77 | 81 | 87 |
| OPM % | 12.6% | 12.0% | 12.5% | 12.3% | 11.8% | 11.3% | 11.6% | 12.5% |
| Other income | 1 | 2 | 1 | 2 | 1 | 19 | 3 | 1 |
| Net profit | 32 | 34 | 34 | 37 | 33 | 46 | 35 | 39 |
| EPS (₹) | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 | 6.34 | 7.02 |
| Revenue YoY | +13.4% | +18.2% | +28.2% | +19.0% | ||||
| Profit YoY | +3.4% | +33.5% | +4.4% | +5.5% |
Consolidated figures where filed. Latest quarter Sep 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 | 2,661 |
| EBITDA | 183 | 223 | 250 | 265 | 286 | 314 |
| Net profit | 98 | 107 | 131 | 136 | 149 | 153 |
| EPS (₹) | 17.81 | 19.46 | 23.67 | 24.66 | 26.95 | 27.58 |
| Revenue growth | +11.7% | +10.5% | +13.6% | +15.2% | +19.8% | |
| Profit growth | +9.8% | +21.8% | +4.4% | +9.4% | +11.8% | |
| Dividend / share (₹) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +13.1% | +27.6% | +19.8% |
| Net profit | +11.6% | +13.2% | +11.8% |
| EPS | +11.5% | +11.6% | – |
| Share price | – | -29.1% (2y) | -35.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 915 | 1,048 | 1,185 | 1,333 |
| Borrowings | – | 74 | 106 | 188 | 408 |
| Cash & equivalents | – | 151 | 68 | 114 | 127 |
| Total assets | – | 1,368 | 1,572 | 1,896 | 2,289 |
| Fixed assets | – | 314 | 315 | 354 | 561 |
| Capital work in progress | – | 13 | 47 | 140 | 173 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 354 | 425 | 474 | 557 |
| Inventory | – | 188 | 282 | 355 | 405 |
| Payables | – | 185 | 219 | 286 | 323 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 29 | 152 | 43 | 137 | 65 |
| Cash from investing | -299 | -181 | -103 | -184 | -219 |
| Cash from financing | 292 | 61 | 16 | 65 | 186 |
| Capex | 38 | 33 | 131 | 159 | 265 |
| Free cash flow | -9 | 120 | -88 | -21 | -200 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 11.7% | 12.5% | 11.5% | 11.2% |
| ROCE % | – | 16.7% | 17.1% | 14.7% | 13.2% |
| Debtor days | – | 78 | 85 | 83 | 85 |
| Inventory days | – | 59 | 80 | 90 | 88 |
| Payable days | – | 58 | 62 | 73 | 71 |
| Cash conversion cycle (days) | – | 79 | 103 | 100 | 102 |
| Working capital days | – | 83 | 84 | 89 | 68 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 68.14% |
| FIIs | 1.84% |
| DIIs | 14.19% |
| of which Mutual funds | 9.11% |
| of which Insurance | 4.01% |
| Government | 0.00% |
| Public (non-institutions) | 15.83% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 68.19% | 68.18% | 68.17% | 68.17% | 68.16% | 68.15% | 68.14% | 68.14% |
| Promoter group | % |
|---|---|
| Edward Menezes | 29.10% |
| Sunil Srinivasan Chari | 13.16% |
| Chari Family Trust in the name of Sunil Srinivasan Chari and Jyotishna Sunil Chari | 9.22% |
| Rossari Biotech India Private Limited | 5.44% |
| Jyotishna Sunil Chari | 4.51% |
| Yash Sunil Chari | 4.45% |
| Anita Menezes | 1.81% |
| Mikhail Menezes | 0.24% |
| Menezes Family Trust in the name of Edward Walter Menezes and Anita Menezes | 0.20% |
| Henry Menezes | 0.00% |
| Yvette Santhmayor | 0.00% |
| Stella Dcunha | 0.00% |
| Charlotte Dmello | 0.00% |
| Priya Shivdasani | 0.00% |
| Malini Nainani | 0.00% |
| Public holders above 1% | % |
|---|---|
| Uti Aggressive Hybrid Fund | 6.36% |
| Life Insurance Corporation of India | 4.01% |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | 1.85% |
| Bhupesh Kumar Lodha | 1.08% |
86,622 shareholders. Pledged: – of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| ROSSARI | ₹2,251 cr | 14.7x | 1.6x | 11.5% | 13.5% | 11.8% | +13.1% | 0.13% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-10 | Dividend | Dividend - Rs 0.50 Per Share |
| 2025-06-20 | Dividend | Dividend - Re 0.50 Per Share |
| 2024-11-04 | Other | Extra Ordinary General Meeting |
| 2024-08-16 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 2023-05-24 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 2022-07-07 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 2021-09-08 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacture of Chemical and Chemical Products: The Company is primarily engaged in the manufacturing of specialty chemicals catering to the Textile, Home and Personal Care, and Animal Health and Nutrition sectors.
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | ROSSARI |
| BSE code | 543213 |
| ISIN | INE02A801020 |
| Face value | ₹2.0 |
| Incorporated | 2009-08-10 |
| Website | www.rossari.com |
| Plants (India / abroad) | 2 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.